Back
Alimera Sciences Quote, Financials, Valuation and Earnings
Sponsored
ALIM
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
61
ALIM
Alimera Sciences
Last Price:
5.54
Seasonality Move:
-15.06%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Alimera Sciences Price Quote
$5.54
Alimera Sciences Key Stats
Buy
61
Alimera Sciences (ALIM)
is a Buy
Day range:
$5.54 - $5.54
52-week range:
$2.61 - $5.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.68
P/B ratio:
7.77%
Volume:
0
Avg. volume:
1.2M
1-year change:
73.67%
Market cap:
$301.3M
Revenue:
$80.8M
EPS:
$-0.31
How Much Does Alimera Sciences Make?
-
How Much Are Alimera Sciences's Sales Annually?
ALIM Revenues are $80.8M -
How Much Profit Does Alimera Sciences's Make A Year?
ALIM net income is -$20.1M
Is Alimera Sciences Growing As A Company?
-
What Is Alimera Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.54% -
What Is Alimera Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Alimera Sciences Stock Price Performance
-
Did Alimera Sciences Stock Go Up Last Month?
Alimera Sciences share price went down by -0.72% last month -
Did ALIM's Share Price Rise Over The Last Year?
ALIM share price rose by 73.67% over the past 1 year
What Is Alimera Sciences 52-Week High & Low?
-
What Is Alimera Sciences’s 52-Week High Share Price?
Alimera Sciences has traded as high as $5.65 over the past 52 weeks -
What Is Alimera Sciences’s 52-Week Low Share Price?
Alimera Sciences has traded as low as $2.61 over the past 52 weeks
Alimera Sciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Alimera Sciences?
-
How Much Debt Does Alimera Sciences Have?
Total long term debt quarterly is $69.7M -
How Much Cash Does Alimera Sciences Have?
Cash and short term investments quarterly total is $10.8M -
What Is Alimera Sciences’s Book Value Per Share?
Book value per share is 0.74
Is Alimera Sciences Cash Flow Positive?
-
What Is ALIM Cash Flow From Operations?
Cash flow from operations (TTM) is -$5.6M -
What Is Alimera Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2M -
What Is Alimera Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$221K
Alimera Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
ALIM return on invested capital is -13.3% -
What Is Alimera Sciences Return On Assets?
ROA measures how assets are converting to revenues and is -9.6% -
What Is ALIM Return On Equity?
ROE is a measure of profitability and is -33.3%
Alimera Sciences Earnings Date & Stock Price
-
What Is Alimera Sciences's Stock Price Today?
A single share of ALIM can be purchased today for 5.54 -
What Is Alimera Sciences’s Stock Symbol?
Alimera Sciences trades on the nasdaq under the ticker symbol: ALIM -
When Is Alimera Sciences’s Next Earnings Date?
The next quarterly earnings date for Alimera Sciences is scheduled on October 25, 2024 -
When Is ALIM's next ex-dividend date?
Alimera Sciences's next ex-dividend date is September 21, 2024 -
How To Buy Alimera Sciences Stock?
You can buy Alimera Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Alimera Sciences Competitors
-
Who Are Alimera Sciences's Competitors?
Below is a list of companies who compete with Alimera Sciences or are related in some way:
Alimera Sciences Dividend Yield
-
What Is ALIM Dividend Yield?
Alimera Sciences’s dividend yield currently is 0% -
What Is Alimera Sciences’s Payout Ratio?
Alimera Sciences’s payout ratio is 0% -
When Did Alimera Sciences Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Alimera Sciences’s Dividend Per Share?
Alimera Sciences pays a dividend of $0.00 per share
Alimera Sciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -339.33% |
Revenue: | 53.95% | 4.93% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 5.67 |
Upside from Last Price: | 2.29% |